Shineco, Inc. is dedicated to enhancing public health and quality of life through the development and provision of high-quality health products and services. The company has made significant strides in the medical field, having researched and developed 33 vitro diagnostic reagents and related medical devices. Their product range includes 15 series and 45 types of point-of-care testing (POCT) products, with a notable presence in both domestic and international markets. Shineco's subsidiary, Changzhou Biowin Pharmaceutical Co., Ltd., holds multiple medical device registration certificates in China and various international certifications, including the EU CE mark and registrations in Australia, Spain, Thailand, and Japan. This extensive certification portfolio underscores the company's commitment to quality and compliance in the healthcare sector.

In addition to its medical device offerings, Shineco also focuses on producing and selling healthy and nutritious food products. The company is actively expanding its research and development efforts to explore new high-tech medical product applications, indicating a forward-looking approach to innovation in health technology. Recent initiatives include entering into distribution agreements for new health food beverages and collaborating with other organizations to develop intelligent healthcare products. These efforts reflect Shineco's strategic vision to address contemporary health challenges, including the needs of an aging population, while maintaining a strong emphasis on safety and efficacy in its product offerings.

China

Shineco, Inc. Changzhou Biowin Pharmaceutical Co., Ltd., a subsidiary of Shineco, is mainly engaged in POCT testing business. According to the different types of diseases...

Shineco

Company Details